Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor–Dependent Repression of Claudin-2-Reference-Cited by-同舟云学术

Microbial-Derived Butyrate Promotes Epithelial Barrier Function through IL-10 Receptor–Dependent Repression of Claudin-2

Published:2017-09-11 Issue:8 Volume:199 Page:2976-2984
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Zheng Leon^ORCID,Kelly Caleb J.^ORCID,Battista Kayla D.,Schaefer Rachel,Lanis Jordi M.^ORCID,Alexeev Erica E.^ORCID,Wang Ruth X.^ORCID,Onyiah Joseph C.,Kominsky Douglas J.,Colgan Sean P.^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. Diversity, stability and resilience of the human gut microbiota

2. Review article: the role of butyrate on colonic function

3. Butyricicoccus pullicaecorumin inflammatory bowel disease

4. A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitis

5. Low counts of Faecalibacterium prausnitzii in colitis microbiota

Cited by 368 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polysaccharides to postbiotics: Nurturing bone health via modulating “gut-immune axis”;International Journal of Biological Macromolecules;2024-10

2. Human milk oligosaccharides in preventing food allergy: A review through gut microbiota and immune regulation;International Journal of Biological Macromolecules;2024-10

3. The role of gut-derived short-chain fatty acids in Parkinson's disease;Neurogenetics;2024-09-13

4. Recent developments and new directions in the use of natural products for the treatment of inflammatory bowel disease;Phytomedicine;2024-09

5. Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model;ACS Pharmacology & Translational Science;2024-08-30